Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$6.60 - $25.00
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | $1.22B |
EV | $1.11B |
Shares Outstanding | 71.28M |
Beta | 1.88 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2023E | - |
P/Revenue 2023E | - |
Revenue | - |
EPS | 8.80% |
Operating Cash Flow | -11.20% |
Free Cash Flow | -15.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2023E | - |
Net Profit Margin 2023E | - |
ROE 2023E | - |
ROCE 2022 | -349.89% |
DPS 2023E | - |
Payout Ratio 2023E | - |
Div. Yield 2023E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Pulse Biosciences, Inc.
PLSE
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Barrett, Burke
Employees
75
Website
www.pulsebiosciences.comIPO Date
2016-05-18
Headquarters
3957 Point Eden Way, Hayward, California, 94545, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved